For the year ending 2025-12-31, HR had -$42,744K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net loss | -249,485 | -663,904 | -282,083 | 40,693 |
| Depreciation and amortization | 563,966 | 675,152 | 730,709 | 453,082 |
| Other amortization | 47,201 | 47,165 | 45,181 | 24,695 |
| Share-based compensation | 22,387 | 31,824 | 14,288 | 20,346 |
| Amortization of straight-line rent receivable (lessor) | 27,106 | 29,996 | 38,676 | 23,498 |
| Amortization of straight-line rent on operating leases (lessee) | 3,354 | 3,880 | 6,084 | 3,374 |
| Loss on derivatives | -4,301 | - | - | - |
| Gain on sales of real estate properties and other assets | 235,389 | 109,753 | 77,546 | 270,271 |
| Loss on extinguishment of debt | - | - | - | -2,401 |
| Loss (gain) on extinguishment of debt | -451 | -237 | 62 | - |
| Impairment of real estate properties and credit loss reserves | 364,598 | 313,547 | 154,912 | 54,427 |
| Impairment of goodwill | 0 | 250,530 | - | - |
| Equity loss from unconsolidated joint ventures | -188 | -135 | -1,682 | -687 |
| Distributions from unconsolidated joint ventures | 21,515 | 10,498 | 17,880 | 1,881 |
| Proceeds from disposition of sales-type lease properties | - | - | - | 0 |
| Non-cash interest from financing and real estate notes receivable | 1,082 | 1,833 | 1,654 | 2,257 |
| Other assets, including right-of-use-assets | 31,463 | 34,547 | 55,946 | 26,098 |
| Accounts payable and accrued liabilities | -25,513 | 5,199 | -18,775 | 24,191 |
| Other liabilities | -828 | 3,483 | 3,826 | -30,906 |
| Net cash provided by operating activities | 457,095 | 501,617 | 499,820 | 272,747 |
| Acquisitions of real estate | 100 | 0 | 49,171 | 402,529 |
| Development of real estate | 12,622 | 70,338 | 41,058 | 37,862 |
| Additional long-lived assets | 330,153 | 248,981 | 231,026 | 163,544 |
| Funding of mortgages and notes receivable | 8,500 | 5,505 | 26,803 | 23,325 |
| Investments in unconsolidated joint ventures | 2,188 | 0 | 3,824 | 99,967 |
| Investment in financing receivable | 502 | 511 | 1,801 | 1,002 |
| Proceeds from sales of real estate properties and additional long-lived assets | 1,004,622 | 1,221,083 | 701,434 | 1,201,068 |
| Contributions from redeemable non-controlling interests | 0 | 13 | 1,389 | - |
| Proceeds from insurance recovery | 2,000 | - | - | - |
| Proceeds from notes receivable repayments | 58,271 | 5,162 | 0 | 1,688 |
| Cash assumed in merger, including restricted cash for special dividend payment | - | 0 | 0 | 1,159,837 |
| Net cash provided by investing activities | 710,828 | 900,923 | 349,140 | 1,634,364 |
| Borrowings on unsecured credit facility | 1,449,000 | 0 | -385,000 | 40,000 |
| Borrowings on term loans | - | 0 | 0 | 666,500 |
| Repayments on unsecured credit facility | 1,329,000 | - | - | - |
| Repayment on term loans | 650,140 | 350,000 | 0 | 1,141,500 |
| Borrowings of notes and bonds payable | - | - | - | 0 |
| Repayments of notes and bonds payable | 266,375 | 25,473 | 19,143 | 20,042 |
| Redemption of notes and bonds payable | - | 0 | 0 | 2,184 |
| Dividends paid | 386,919 | 457,853 | 472,242 | 283,713 |
| Special dividend paid in relation to the merger | - | 0 | 0 | 1,123,648 |
| Net proceeds from issuance of common stock | 0 | 104 | 130 | 22,902 |
| Common stock redemptions | 4,007 | 8,881 | 2,298 | 3,192 |
| Common stock repurchases | 0 | 510,423 | - | - |
| Distributions to non-controlling interest holders | 4,927 | 5,473 | 5,123 | 1,695 |
| Redemption of non-controlling interest | 834 | 744 | - | - |
| Settlement of interest rate swaps | 4,329 | - | - | 0 |
| Debt issuance and assumption costs | 13,083 | 563 | 529 | 12,753 |
| Payments made on finance leases | 53 | 17 | 17 | 0 |
| Net cash used in financing activities | -1,210,667 | -1,359,323 | -884,222 | -1,859,325 |
| (decrease) increase in cash and cash equivalents | -42,744 | 43,217 | -35,262 | 47,786 |
| Cash and cash equivalents at beginning of period | 68,916 | 25,699 | 60,961 | 13,175 |
| Cash and cash equivalents at end of period | 26,172 | 68,916 | 25,699 | 60,961 |
Healthcare Realty Trust Inc (HR)
Healthcare Realty Trust Inc (HR)